Sanofi S.A., France’s largest pharmaceutical company, announced in a statement on September 1st that it would not be continuing work on a Zika vaccine that it has been developing since July 2016. The project, funded by a $43 million grant from the United States government’s Biomedical Advanced Research and Development Authority, will continue to be […]